Search

Author/Creator Wang, Bi-Yun

1. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial. Issue 4 (April 2015)

Authors:
Hu, Xi-Chun; Zhang, Jian; Xu, Bing-He; Cai, Li; Ragaz, Joseph; Wang, Zhong-Hua; Wang, Bi-Yun; Teng, Yue-E; Tong, Zhong-Sheng; Pan, Yue-Yin; Yin, Yong-Mei; Wu, Chang-Ping; Jiang, Ze-Fei; Wang, Xiao-Jia; Lou, Gu-Yin; Liu, Dong-Geng; Feng, Ji-Feng; Luo, Jian-Feng; Sun, Kang; Gu, Ya-Jia
Journal:
Lancet oncology
Issue:
Volume 16:Issue 4(2015:Apr.)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial. Issue 4 (April 2015)

Authors:
Hu, Xi-Chun; Zhang, Jian; Xu, Bing-He; Cai, Li; Ragaz, Joseph; Wang, Zhong-Hua; Wang, Bi-Yun; Teng, Yue-E; Tong, Zhong-Sheng; Pan, Yue-Yin; Yin, Yong-Mei; Wu, Chang-Ping; Jiang, Ze-Fei; Wang, Xiao-Jia; Lou, Gu-Yin; Liu, Dong-Geng; Feng, Ji-Feng; Luo, Jian-Feng; Sun, Kang; Gu, Ya-Jia
Journal:
Lancet oncology
Issue:
Volume 16:Issue 4(2015:Apr.)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. Issue 1 (December 2015)

Authors:
Wang, Bi-Yun; Zhang, Jian; Wang, Jia-Lei; Sun, Si; Wang, Zhong-Hua; Wang, Lei-Ping; Zhang, Qun-Ling; Lv, Fang-Fang; Cao, En-Ying; Shao, Zhi-Min; Fais, Stefano; Hu, Xi-Chun
Journal:
Journal of experimental & clinical cancer research
Issue:
Volume 34:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. Issue 1 (December 2015)

Authors:
Wang, Bi-Yun; Zhang, Jian; Wang, Jia-Lei; Sun, Si; Wang, Zhong-Hua; Wang, Lei-Ping; Zhang, Qun-Ling; Lv, Fang-Fang; Cao, En-Ying; Shao, Zhi-Min; Fais, Stefano; Hu, Xi-Chun
Journal:
Journal of experimental & clinical cancer research
Issue:
Volume 34:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. Issue 1 (December 2015)

Authors:
Wang, Bi-Yun; Zhang, Jian; Wang, Jia-Lei; Sun, Si; Wang, Zhong-Hua; Wang, Lei-Ping; Zhang, Qun-Ling; Lv, Fang-Fang; Cao, En-Ying; Shao, Zhi-Min; Fais, Stefano; Hu, Xi-Chun
Journal:
Journal of experimental & clinical cancer research
Issue:
Volume 34:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗